Feb 21, 2023 | Comparative Effectiveness, Drug advertising, MedBen Rx, Research, TruDataRx
Drug companies spend $6 billion per year on direct-to-consumer ads with the goal of getting patients to ask their doctors to prescribe drugs that, in many instances, cost substantially more but are less effective than their current medications. And with no comparative...
Feb 6, 2023 | Announcements, Benchmarks, Case Studies, Compliance, Direct-to-Employer Contracting, MedBen Rx, MedBen University, Roundtables, Rx Costs, Specialty Drugs, Supreme Court
The 22nd Season of MedBen University (MBU) will soon be in session! In 2023, MBU will explore current benefit management issues and proven solutions MedBen offers, including: Reducing Rx spend through alternative specialty drug funding, as well as other pharmacy plan...
Feb 3, 2023 | Alternative Reimbursement Strategies, Claims, Cost Savings, Direct-to-Employer Contracting, Drug costs, Forensic claims review, Gene therapy, Health care costs, Inflation, MedBen Rx, MedBen WellLiving, Prescription, Rx Costs, Savings, Specialty Drugs, Wellness
Even though health care costs have not seen the same rate of inflation as other industries, that’s about to change. Fortunately, MedBen has a variety of inflation-hedging solutions to counter rising costs. As a recent Self-Insurer article notes, health care...
Feb 1, 2023 | Legislative, MedBen Rx, Pharmacy Benefits Manager (PBM), Rx Costs
Pharmacy benefits managers (PBMs) are increasingly being called to answer for their questionable business practices at multiple levels of government. On the state level, in recent months: A major PBM has settled with Iowa and at least 14 other states for overbilling...
Jan 23, 2023 | Avande, Cost Savings, Drug costs, Gene therapy, Luke Burchard, MedBen Rx, Rx Costs, Savings
In two recent articles, we touched on the growing prevalence of high-cost drugs, some with price tags in the thousands and even millions of dollars: Drugmakers are raising prices on over 350 unique drugs this month.Innovative gene therapies have emerged that cost as...
Dec 27, 2022 | Alternative Reimbursement Strategies, Client Surveys, Kurt Harden, MedBen Rx, Prescription, Reference-Based Pricing, Regulatory
On behalf of our entire team, I wish you a Happy New Year and thank you for your continued business with MedBen. We often say that “MedBen Delivers,” and it’s a statement that covers a variety of factors such as plan design strategies, claims processing accuracy, and...
